Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic



Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic (H2020 - Convocatoria Expres (SC1-PHE-CORONAVIRUS-2020))


The I-MOVE-COVID-19 project has been granted under the European Commission H2020 call on “Advancing knowledge for the clinical and public health response to the novel coronavirus epidemic”. The I-MOVE-COVID-19 consortium aims to obtain epidemiological and clinical information on patients with COVID-19 as well as virological information on SARS-CoV-2, through:

A. provision of a flexible surveillance platform (adaptable to the epidemiological situation)
B. research studies
C. evaluation of public health interventions (e.g. vaccination, antivirals),

in order to contribute to the knowledge base, guide patient management, and inform the public health response.

This will be achieved through adaptation and expansion of the existing, long-running, Europe-wide influenza surveillance network (I-MOVE) to include COVID-19. The network includes primary care networks, hospitals, and national laboratory reference centres in 12 countries across the WHO European Region.

Objetivos y Resultados

The main work packages (WP) pool studies in both Primary Care and Hospital Networks in order to:
- gather information from the sentinel surveillance systems to rapidly detect, describe and report Covid-19 cases, based on common protocols.
- contribute to priority questions and knowledge gaps on the epidemiology of COVID-19 and specific virological characteristics of SARS-CoV-2.

WP1: Coordination. Epiconcept, France.
WP2: Primary care network. NIVEL, the Netherlands.
WP3: Hospital network. Health Protection Scotland.
WP4: Pooled epidemiological, clinical, virological studies. Epiconcept, France.

IIS Aragón is working, together with the ISCIII, in the Hospital network through the Hospital Universitario Miguel Servet.

IP IIS Aragón

Ana Mª Milagro

Organismo Financiador

The I-MOVE-COVID-19 network has received funding from the European Commission (from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 101003673).

Total budget: 2.548.162,50 €


Epiconcept (Francia)


23 socios de 12 países diferentes.


16/03/2020 – 15/06/2022 (27 meses)